Clusterin: A Marker and Mediator of Chemoresistance in Colorectal Cancer

Scientists discuss recent insights on clusterin (CLU) in colorectal cancer and its roles in enhancing the plasticity of cells and further consider the implications of CLU as a prospective target for therapeutic intervention.